CIP2A


Currently my research work is focusing on CIP2A biology in both CML and AML. My current research can be outlined in four themes, 1. Identifying novel CIP2A binding partners. 2. Validating CIP2A as a biomarker of clinical outcome in the UK SPIRIT 2 clinical trial. 3. Does CIP2A predict clinical outcome in AML- manuscript in preparation for leukemia, and the importance of the CIP2A/AKT pathway in AML. 4. CIP2A regulation of BCL2 family members in AML and CML.